EU solidarity with Ukraine
Prozorro+: Ukrainian public procurement platform
Spain-Barcelona: Research and experimental development services
Prior information notice
This notice is for prior information only
Section I: Contracting authority
The contract involves Joint Procurement. Additional information about the Joint Procurement can be found in Section VI.3) Additional information.
Section II: Object
Pre-Commercial Procurement to Buy R&D (Research and Development) Services to Deliver Quick Responses for Individuals with Advanced Heart Failure and Complex Care Needs Through Integrated Care (TIQUE)
This PIN provides early information about the expected starting date and purchase volume for a pre-commercial procurement (PCP) and about the open market consultation (OMC) that is organised in preparation of this procurement. See sections II.2.4) and II.2.14) for details.
The procurement aims to trigger new solutions to be developed and tested to address the following challenge: improve treatment for patients with advanced heart failure and complex care needs through technology enabled integrated care solutions.
The main target improvements are:
• 33 % increase of patient life expectancy;
• 40 % reduction of acute hospital admission;
• 20 % reduction of drug-related health problems;
• 20 % increase of home care attention; and
• 10 % increase of end-of-life care at home.
This PCP procurement is a joint procurement by different procurers across Europe that are all facing the same common challenge and are thus looking for similar solutions (so-called ‘buyers group’).
R&D services to be developed will be integrated with resources in centres operated by buyers group.
The TIQUE Buyers Group of healthcare providers have identified a common need for the transformation of health and care services for patients with advanced heart failure and co-existing chronic conditions, frail or at risk of becoming frail, specifically solutions to implement integrated care approaches to treatment for those patients.
The procurement will take the form of a pre-commercial procurement (PCP) under which R&D service contracts will be awarded to a number of R&D providers in parallel in a phased approach. This will make it possible to compare competing alternative solutions.
Each selected operator will be awarded a framework agreement that covers 3 R&D phases.
The 3 phases are:
— solution design;
— original development and validation and testing of a limited set of first products or services.
After each phase, intermediate evaluations will be carried out to progressively select the best of the competing solutions. The contractors with the best-value-for-money solutions will be offered a specific contract for the next phase.
Testing is expected to take place in Barcelona, Region Västerbotten and Avellino. This testing may also serve as a first customer test reference for the contractors. The procurement is expected to start in spring 2022 and end in February 2026.
The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions i.e. beyond the procurement.
Over 15 000 000 people live with Heart failure in Europe, it is the leading cause of hospital income in people over 65 years, has a mortality of 75 % at 5 years of 1st admission and over 50 % of Health expenditure is produced in the last 6 months of life. The market potential for integrated care for these patients with complex needs is considerable.
More information about PCP can be found on the EC website https://ec.europa.eu/digital-single-market/en/innovation-procurement.
Currently, the TIQUE buyers group with the knowledge partners are conducting a co-creation process to define the challenge to be addressed. Initial findings show a number of challenges to be addressed by TIQUE solutions, as:
(a) fragmentation: difficulty to communicate with other hospital services and departments of the healthcare systems such as municipalities, social services, psychological assistance; etc.
(b) interoperability: even within a given regional healthcare setting IT systems cannot always communicate or share information;
(c) need for remote care: technology allows that clinical test, measurement of variables, treatments and rehabilitation can be remote;
(d) digital literacy: for patients of all ages, healthcare professionals and other healthcare stakeholders.
In preparation for the TIQUE PCP, all interested operators are invited to take part in an Open Market Consultation (OMC) to help inform the strategy and specifications. Four OMC online events have been planned to provide an opportunity for potential suppliers to engage directly with the Buyers and ask questions. It is also planned to facilitate active discussion and opportunities for networking between organisations.
The anticipated dates of the meetings are as follows:
• Barcelona, on 7 October 2021, in English;
• Avellino, on 14 October 2021, in Italian;
• Västerbottens län, on 21 October 2021, in English;
• International meeting, on 4 November 2021, in English.
Note: due to the current conditions these dates are subject to change and interested parties should check the registration page for confirmed dates.
The OMC will provide you with an overview on the PCP process and the main clauses of the contract. You can participate in the PCP call for tender even if you did not participate in the OMC.
All information regarding the OMC and the information provided during the consultation will be published on the TIQUE PCP website: https://tiquepcp.eu/
This procurement is funded by the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No 965356 — TIQUE (https://tiquepcp.eu/). The EU has awarded a grant for this procurement but is not participating as a contracting authority in the procurement.
Offers will be accepted in English. All communication regarding this PCP will be carried out in English.
Section IV: Procedure
Section VI: Complementary information
This pre-commercial procurement (PCP) is carried out by: Fundació de Gestió Sanitària de l’Hospital de la Santa Creu i Sant Pau (HSP) who was appointed as lead procurer to coordinate and lead the joint procurement in the name and on behalf of the buyers group listed in I.1). The applicable national procurement law is the Spanish Law 9/2017, of November 8, on Public Sector Contracts, by which the Directives of the European Parliament and of the Council 2014/23/EU and 2014/24/EU, of February 26, are transposed into the Spanish legal system 2014.
The new solution(s) are expected, through a co-creation with the Buyers Group, to deliver:
(a) effective provision proactive care through early detection of potential decompensations and activation of health and care services;
(b) coordinated follow-up through a multidisciplinary and multi-organisational health and care team to deliver integrated health and care services tailored to patient’s needs and wills;
(c) patient empowerment to inform and educate patients and relatives to self-manage, end-of-life planning and decisions making;
(d) adaptability to different healthcare models;
(e) value based healthcare characterisation of financial solutions to implement sustainable solutions maximising the value for patients.
All interested operators are invited to take part in an open market consultations (OMCs) (regardless of their geographic location, the size or governance structure of their organisation). The open market consultations will provide you with an overview on the procurement objectives, the PCP process and the main clauses of the contract. You will also have the opportunity to ask questions. They will be held in English and Italian. The open market consultation will be organised in the form of an online event.
More information about the OMCs is in section II.2.4) above.
You can participate in the PCP call for tender even if you did not participate in the OMC.
All information provided during the OMC and other background will be published in English on https://tiquepcp.eu/.
Offers will be accepted in English. All communication regarding this PCP procurement will be carried out in English.
This procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them. This is because it concerns the procurement of R&D services where the benefits do not accrue exclusively to the contracting authority for its use in the conduct of its own affairs.
Publication of this contract notice in the EU Official Journal is not to be understood as a waiver of this exemption. Publication is made on a voluntary basis and the procurement will not follow the procedures under the EU public procurement directives, but rather the procedure described in the tender documentation.
This PIN is published to announce an open market consultation on a future procurement procedure. The PIN is not a commitment to procure.